Indeed mannosyl-based dendrimers, liposomes or nanoparticles [229,251,252,253,254] or even tumour-specific highly mannosylated peptides conjugated with a TLR7 ligand [229], successfully achieved multivaling presentation and enhanced binding to DC-SIGN. Here, CD209 is linked to neoplasm.